TMPRSS2 and chromophobe renal cell carcinoma: On the contrary, elevated expression of TMPRSS2 was reported in bladder urothelial carcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma, cholangiocarcinoma, glioblastoma multiforme, kidney chromophobe, uterine corpus endometrial carcinoma, and pancreatic and prostate adenocarcinoma [55].